Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer
Lukas Löfling, Anders Sundström, Helle Kieler, Shahram Bahmanyar, Marie Linder Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institute, Solna, Sweden Introduction: One out of six adults has symptoms of overactive bladder (OAB).Antimuscarinic medication is the main pharmacological group used in the treatment of OAB.In